CAMP and cancer: When hCAP-18 is cleaved by serine proteases, leucine-leucine-37 (LL-37) is produced and has been reported to be involved in adaptive immunity, growth inhibition, chemotaxis, and wound healing, and specifically induces destabilization of the cancer cell membrane by toroidal pore mechanism [74].